NEA 16 Amends Trevi Therapeutics Stake Filing
Ticker: TRVI · Form: SC 13D/A · Filed: Nov 8, 2024 · CIK: 1563880
Sentiment: neutral
Topics: ownership-change, sec-filing, amendment
TL;DR
NEA 16 just updated their Trevi Therapeutics filing - big ownership change incoming.
AI Summary
New Enterprise Associates 16, L.P. (NEA 16) filed an amendment to its Schedule 13D on November 8, 2024, regarding its holdings in Trevi Therapeutics, Inc. The filing indicates a change in beneficial ownership, with NEA 16 and its affiliated entities now holding a significant stake in the company. Specific details on the exact percentage or number of shares are not immediately available in this excerpt, but the filing signifies a material update to their investment position.
Why It Matters
This filing signals a potential shift in the ownership structure or investment strategy of Trevi Therapeutics, Inc., which could impact its stock price and future corporate actions.
Risk Assessment
Risk Level: medium — Amendments to Schedule 13D filings often indicate significant changes in a major shareholder's position, which can lead to increased volatility.
Key Players & Entities
- New Enterprise Associates 16, L.P. (company) — Filing entity
- Trevi Therapeutics, Inc. (company) — Subject company
- NEA 16 GP, LLC (company) — Affiliated entity
- NEA PARTNERS 16, L.P. (company) — Affiliated entity
- ALI BEHBAHANI (person) — Group member
- ANTHONY A. FLORENCE, JR. (person) — Group member
- CARMEN CHANG (person) — Group member
- FOREST BASKETT (person) — Group member
- MOHAMAD H. MAKHZOUMI (person) — Group member
- PAUL WALKER (person) — Group member
FAQ
What specific changes in beneficial ownership are detailed in this SC 13D/A filing for Trevi Therapeutics, Inc.?
The filing is an amendment to a Schedule 13D, indicating a change in beneficial ownership by New Enterprise Associates 16, L.P. and its affiliated entities. Specific details on the exact number of shares or percentage of ownership change are not provided in the excerpt.
Who are the primary entities involved in this SC 13D/A filing concerning Trevi Therapeutics, Inc.?
The primary entities are New Enterprise Associates 16, L.P. (NEA 16) as the filer, and Trevi Therapeutics, Inc. as the subject company.
When was this SC 13D/A filing submitted to the SEC?
This SC 13D/A filing was submitted on November 8, 2024.
What is the business address of Trevi Therapeutics, Inc. according to this filing?
The business address of Trevi Therapeutics, Inc. is 195 Church Street, 14th Floor, New Haven, CT 06510.
What is the SIC code for Trevi Therapeutics, Inc.?
The Standard Industrial Classification (SIC) code for Trevi Therapeutics, Inc. is 2834, which corresponds to Pharmaceutical Preparations.
Filing Stats: 4,717 words · 19 min read · ~16 pages · Grade level 10.5 · Accepted 2024-11-08 18:57:55
Key Financial Figures
- $0.001 — Inc. (Name of Issuer) Common Stock, $0.001 par value (Title of Class of Securiti
Filing Documents
- nea16-trevi_18901.htm (SC 13D/A) — 501KB
- 0001072613-24-000813.txt ( ) — 503KB
From the Filing
SC 13D/A 1 nea16-trevi_18901.htm NEW ENTERPRISE ASSOCIATES 16, L.P. / TREVI THERAPEUTICS, INC. -- SCHEDULE 13D/A(#5) Schedule 13D UNITED SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 5)* Trevi Therapeutics, Inc. (Name of Issuer) Common Stock, $0.001 par value (Title of Class of Securities) 89532M101 (CUSIP Number) Stephanie Brecher New Enterprise Associates 1954 Greenspring Drive, Suite 600 Timonium, MD 21093 (410) 842-4000 (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications) November 6, 2024 (Date of Event which Requires Filing of this Statement) If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box. Note : Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See §240.13d-7 for other parties to whom copies are to be sent. * The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page. The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). CUSIP No.89532M101 13D Page 2 of 25 Pages 1 NAMES OF REPORTING PERSONS. New Enterprise Associates 16, L.P. 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (see instructions) (a) (b) 3 SEC USE ONLY 4 SOURCE OF FUNDS (see instructions) WC 5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e) 6 CITIZENSHIP OR PLACE OF ORGANIZATION Delaware NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH 7 SOLE VOTING POWER 0 Shares 8 SHARED VOTING POWER 15,074,080 Shares 9 SOLE DISPOSITIVE POWER 0 Shares 10 SHARED DISPOSITIVE POWER 15,074,080 Shares 11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 15,074,080 Shares 12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (see instructions) 13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 18.7% 14 TYPE OF REPORTING PERSON (see instructions) PN CUSIP No.89532M101 13D Page 3 of 25 Pages 1 NAMES OF REPORTING PERSONS. NEA Partners 16, L.P. 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (see instructions) (a) (b) 3 SEC USE ONLY 4 SOURCE OF FUNDS (see instructions) AF 5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e) 6 CITIZENSHIP OR PLACE OF ORGANIZATION Delaware NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH 7 SOLE VOTING POWER 0 Shares 8 SHARED VOTING POWER 15,074,080 Shares 9 SOLE DISPOSITIVE POWER 0 Shares 10 SHARED DISPOSITIVE POWER 15,074,080 Shares 11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 15,074,080 Shares 12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (see instructions) 13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 18.7% 14 TYPE OF REPORTING PERSON (see instructions) PN CUSIP No.89532M101 13D Page 4 of 25 Pages 1 NAMES OF REPORTING PERSONS. NEA 16 GP, LLC 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (see instructions) (a) (b) 3 SEC USE ONLY 4 SOURCE OF FUNDS (see instructions) AF 5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e) 6 CITIZENSHIP OR PLACE OF ORGANIZATION Delaware NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH 7 SOLE VOTING POWER 0 Shares 8 SHARED VOTING POWER 15,074,080 Shares 9 SOLE DISPOSITIVE POWER 0 Shares 10 SHARED DISPOSITIVE POWER 15,074,080 Shares 11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 15,074,080 Shares 12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (see instructions) 13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 18.7% 14 TYPE OF REPORTING PERSON (see instructions) OO CUSIP No.89532M101 13D Page 5 of 25 Pages 1 NAMES OF REPORTING PERSONS. NEA 18 Venture Growth Equity, L.P. 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (see instructions) (a) (b) 3 SEC USE ONLY 4 SOURCE OF FUNDS (see instructions) WC 5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUAN